EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases

Nazareno Carullo, Giuseppe Fabiano, Mario D'Agostino iD, Maria Teresa Zicarelli, Michela Musolino, Pierangela Presta, Ashour Michael, Michele Andreucci iD, Davide Bolignano iD, Giuseppe Coppolino iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241311186 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nazareno Carullo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Renal Unit, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy. Hauptthemen laut MEDLINE: Bufanolides, Cardiac Glycosides, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marinobufagenin (MBG) is a member of the bufadienolide family of compounds, which are natural cardiac glycosides found in a variety of animal species, including man, which have different physiological and biochemical functions but have a common action on the inhibition of the adenosine triphosphatase sodium-potassium pump (Na+/K+-ATPase). MBG acts as an endogenous cardiotonic steroid, and in the last decade, its role as a pathogenic factor in various human diseases has emerged. In this paper, we have collated major evidence regarding the biological characteristics and functions of MBG and its implications in human pathology. This review focused on MBG involvement in chronic kidney disease, including end-stage renal disease, cardiovascular diseases, sex and gender medicine, and its actions on the nervous and immune systems. The role of MBG in pathogenesis and the development of a wide range of pathological conditions indicate that this endogenous peptide could be used in the future as a diagnostic biomarker and/or therapeutic target, opening important avenues of scientific research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BufanolidesCardiac GlycosidesRenal Insufficiency, ChronicMaleAnimalsFemaleHumansSodium-Potassium-Exchanging ATPase

Stichwörter der Autor:innen

Marinobufagenin (MBG)chronic kidney diseaseend-stage renal disease (ESRD)nervous and immune systems

Substanzen

marinobufageninBufanolidesCardiac GlycosidesSodium-Potassium-Exchanging ATPase

Autor:innen und Institutionen

  • Renal Unit, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

ORCID-Profile: Mario D'Agostino, Michele Andreucci, Davide Bolignano, Giuseppe Coppolino

Zitieren

APA

Carullo, N., Fabiano, G., D'Agostino, M., Zicarelli, M. T., Musolino, M., Presta, P., Michael, A., Andreucci, M., Bolignano, D., & Coppolino, G. (2023). New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241311186

Vancouver

Carullo N, Fabiano G, D'Agostino M, Zicarelli MT, Musolino M, Presta P, et al. New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241311186

BibTeX
@article{Carullo2023,
  author = {Carullo, Nazareno and Fabiano, Giuseppe and D'Agostino, Mario and Zicarelli, Maria Teresa and Musolino, Michela and Presta, Pierangela and Michael, Ashour and Andreucci, Michele and Bolignano, Davide and Coppolino, Giuseppe},
  title = {New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241311186}
}
Kostenlos starten →